Fig. 3From: Pharmaceutical expenditure on drugs for rare diseases in Canada: a historical (2007–13) and prospective (2014–18) MIDAS sales data analysisCurrent (2007–2013) and Future (2014–2018) Total Drug SpendingBack to article page